Bbg Advanced Therapies
EIN 462216869 · 501(c)(3) · Public charity · San Antonio, TX · recognized 2014
- Assets
- $23.7M
- Revenue
- $5.4M
- Expenses
- $16.0M
- Investment income
- $0
Form 990 fiscal year ended 12/31/2024
Investment managers
Advisory firms linked via Form 990 Part VII independent contractors.
No linked investment managers yet.
Highest-paid contractors
Form 990 Part VII-B, independent contractors paid over $100k.
| Contractor | Services | Compensation |
|---|---|---|
| Cam Pharmaceutical Consulting Llc | Biotech consulting services |
Officers & directors
Form 990 Part VII-A for the latest fiscal year.
| Name | Title | Compensation | Other |
|---|---|---|---|
| Geoffrey Kindt | General manager, biomanufacturing (thru 11/02/2024) | $289,443 | $84,913 |
| Rogelio Zamilpa | Executive director, biomanufacturing & collab | $215,099 | $27,522 |
| Mari Lane Salmi | Sr. director, process dev & cell therapies | $203,361 | $40,993 |
| Milton Masayuki Pollard | Vp, gencure operations (thru 07/09/2024) | $196,274 | $23,473 |
| Amanda Whitelonis | Principal global market development (effective 11/03/2024) | $191,994 | $27,276 |
| Miguel Garza | Director, operations biomanufacturing | $156,301 | $19,855 |
| Biobridge Global | Sole member | $0 | $0 |